Prognostic Impact of HOTAIR Expression is Restricted to ER-Negative Breast Cancers

Yesim Polar, I. Tudor Vladislav, Yaseswini Neelamraju, Sarath C. Janga, Sunil Badve

Research output: Contribution to journalArticle

39 Citations (Scopus)

Abstract

Expression of HOX transcript antisense intergenic RNA (HOTAIR), a large intergenic noncoding RNA (lincRNA), has been described as a metastases-associated lincRNA in various cancers including breast, liver and colon cancer cancers. We sought to determine if expression of HOTAIR could be used as a surrogate for assessing nodal metastases and evaluated RNA in situ hybridization (RNA-ISH) assay in a tissue microarray constructed from 133 breast cancer patients. The prognostic value of HOTAIR was further validated in large cohorts using The Cancer Genome Atlas (TCGA) breast cancer subjects. RNA-ISH analysis was successful in 94 cases (17% cases scored 0, 32.9% scored 1, 30.8% scored 2, and 19.1% scored 3). The expression of HOTAIR did not correlate with nodal metastasis regardless of the scoring intensity or with other study parameters (age, tumor size and grade, expression status). Further analysis of TCGA dataset showed that HOTAIR expression was lower in ductal carcinomas but higher in ER-negative tumors. Overexpression of HOTAIR was not associated with nodal metastases or prognosis in ER-positive patients. Its function as a poor prognostic indicator in ER-negative patients was restricted to node-positive patients. HOTAIR appears to be a marker for lymphatic metastases rather than hematogenous metastases in ER-negative patients.

Original languageEnglish
Article number8765
JournalScientific Reports
Volume5
DOIs
StatePublished - 2015

Fingerprint

Antisense RNA
Breast Neoplasms
Neoplasm Metastasis
Untranslated RNA
Atlases
Neoplasms
Colonic Neoplasms
In Situ Hybridization
Genome
RNA
Lymphatic Metastasis
Ductal Carcinoma
Liver Neoplasms

ASJC Scopus subject areas

  • General

Cite this

Prognostic Impact of HOTAIR Expression is Restricted to ER-Negative Breast Cancers. / Polar, Yesim; Vladislav, I. Tudor; Neelamraju, Yaseswini; Janga, Sarath C.; Badve, Sunil.

In: Scientific Reports, Vol. 5, 8765, 2015.

Research output: Contribution to journalArticle

Polar, Yesim ; Vladislav, I. Tudor ; Neelamraju, Yaseswini ; Janga, Sarath C. ; Badve, Sunil. / Prognostic Impact of HOTAIR Expression is Restricted to ER-Negative Breast Cancers. In: Scientific Reports. 2015 ; Vol. 5.
@article{91d00b54eb7c49d3a997e2a55bb2a403,
title = "Prognostic Impact of HOTAIR Expression is Restricted to ER-Negative Breast Cancers",
abstract = "Expression of HOX transcript antisense intergenic RNA (HOTAIR), a large intergenic noncoding RNA (lincRNA), has been described as a metastases-associated lincRNA in various cancers including breast, liver and colon cancer cancers. We sought to determine if expression of HOTAIR could be used as a surrogate for assessing nodal metastases and evaluated RNA in situ hybridization (RNA-ISH) assay in a tissue microarray constructed from 133 breast cancer patients. The prognostic value of HOTAIR was further validated in large cohorts using The Cancer Genome Atlas (TCGA) breast cancer subjects. RNA-ISH analysis was successful in 94 cases (17{\%} cases scored 0, 32.9{\%} scored 1, 30.8{\%} scored 2, and 19.1{\%} scored 3). The expression of HOTAIR did not correlate with nodal metastasis regardless of the scoring intensity or with other study parameters (age, tumor size and grade, expression status). Further analysis of TCGA dataset showed that HOTAIR expression was lower in ductal carcinomas but higher in ER-negative tumors. Overexpression of HOTAIR was not associated with nodal metastases or prognosis in ER-positive patients. Its function as a poor prognostic indicator in ER-negative patients was restricted to node-positive patients. HOTAIR appears to be a marker for lymphatic metastases rather than hematogenous metastases in ER-negative patients.",
author = "Yesim Polar and Vladislav, {I. Tudor} and Yaseswini Neelamraju and Janga, {Sarath C.} and Sunil Badve",
year = "2015",
doi = "10.1038/srep08765",
language = "English",
volume = "5",
journal = "Scientific Reports",
issn = "2045-2322",
publisher = "Nature Publishing Group",

}

TY - JOUR

T1 - Prognostic Impact of HOTAIR Expression is Restricted to ER-Negative Breast Cancers

AU - Polar, Yesim

AU - Vladislav, I. Tudor

AU - Neelamraju, Yaseswini

AU - Janga, Sarath C.

AU - Badve, Sunil

PY - 2015

Y1 - 2015

N2 - Expression of HOX transcript antisense intergenic RNA (HOTAIR), a large intergenic noncoding RNA (lincRNA), has been described as a metastases-associated lincRNA in various cancers including breast, liver and colon cancer cancers. We sought to determine if expression of HOTAIR could be used as a surrogate for assessing nodal metastases and evaluated RNA in situ hybridization (RNA-ISH) assay in a tissue microarray constructed from 133 breast cancer patients. The prognostic value of HOTAIR was further validated in large cohorts using The Cancer Genome Atlas (TCGA) breast cancer subjects. RNA-ISH analysis was successful in 94 cases (17% cases scored 0, 32.9% scored 1, 30.8% scored 2, and 19.1% scored 3). The expression of HOTAIR did not correlate with nodal metastasis regardless of the scoring intensity or with other study parameters (age, tumor size and grade, expression status). Further analysis of TCGA dataset showed that HOTAIR expression was lower in ductal carcinomas but higher in ER-negative tumors. Overexpression of HOTAIR was not associated with nodal metastases or prognosis in ER-positive patients. Its function as a poor prognostic indicator in ER-negative patients was restricted to node-positive patients. HOTAIR appears to be a marker for lymphatic metastases rather than hematogenous metastases in ER-negative patients.

AB - Expression of HOX transcript antisense intergenic RNA (HOTAIR), a large intergenic noncoding RNA (lincRNA), has been described as a metastases-associated lincRNA in various cancers including breast, liver and colon cancer cancers. We sought to determine if expression of HOTAIR could be used as a surrogate for assessing nodal metastases and evaluated RNA in situ hybridization (RNA-ISH) assay in a tissue microarray constructed from 133 breast cancer patients. The prognostic value of HOTAIR was further validated in large cohorts using The Cancer Genome Atlas (TCGA) breast cancer subjects. RNA-ISH analysis was successful in 94 cases (17% cases scored 0, 32.9% scored 1, 30.8% scored 2, and 19.1% scored 3). The expression of HOTAIR did not correlate with nodal metastasis regardless of the scoring intensity or with other study parameters (age, tumor size and grade, expression status). Further analysis of TCGA dataset showed that HOTAIR expression was lower in ductal carcinomas but higher in ER-negative tumors. Overexpression of HOTAIR was not associated with nodal metastases or prognosis in ER-positive patients. Its function as a poor prognostic indicator in ER-negative patients was restricted to node-positive patients. HOTAIR appears to be a marker for lymphatic metastases rather than hematogenous metastases in ER-negative patients.

UR - http://www.scopus.com/inward/record.url?scp=84924386080&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=84924386080&partnerID=8YFLogxK

U2 - 10.1038/srep08765

DO - 10.1038/srep08765

M3 - Article

C2 - 25739705

AN - SCOPUS:84924386080

VL - 5

JO - Scientific Reports

JF - Scientific Reports

SN - 2045-2322

M1 - 8765

ER -